Dr. Ravi Gurujal, MD

Dr. Gurujal practices at Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health.

Dr. Gurujal's NPI, 1467563957, was assigned on August 31, 2006. Dr. Gurujal holds Ohio license 35.120296.

Dr. Gurujal's primary practice is Charleston Area Medical Center General Hospital, at 501 Morris Street, Charleston, WV 25301 in Kanawha County. The practice phone is (304) 388-5432.

Dr. Gurujal's primary practice is Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health. Dr. Gurujal is also affiliated with Select Specialty Hospital - Charleston. The medical group on file is Charleston Area Medical Center. Dmand AI also links Dr. Gurujal to 4 more hospitals, 8 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gurujal practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Gurujal's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Gurujal's licenses on file in 4 states: Ohio, Illinois, Indiana and Kentucky.

CMS data shows 515 Medicare services from Dr. Gurujal across 14 procedure codes in 2024, for 269 Medicare patients. Medicare paid $39,764 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 269 Medicare patients who saw Dr. Gurujal in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gurujal's median patient age at 74, with 47% women.

In 2024, Dr. Gurujal wrote 216 Medicare Part D claims for 57 patients. 82% of them were for generic drugs. CMS names the drug for 100 of them, across 7 drugs with 11 or more claims each, at $15,108 in total drug cost. In 2023, CMS named 123 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gurujal for performance year 2024, reported as part of a group. Dr. Gurujal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gurujal as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Gurujal in 2018. 2018 was the busiest year, with 4. Dr. Gurujal has published most often in Oxf Med Case Reports. Dr. Gurujal's most frequent co-authors are Thomas Paul Vacek, MD, MS, Mohammed Abdulrazzaq and Islam Abudayyeh, MD.

CMS Open Payments shows 328 general payments to Dr. Gurujal from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Boston Scientific Corporation paid the most, $5,593.